Navigation Links
AMRI Announces Fourth Quarter 2012 Adjusted EPS of $0.17
Date:2/12/2013

mmission on March 15, 2012, and the company's other SEC filings. Revenue, adjusted EPS and other financial guidance offered by senior management today represent a point-in-time estimate and are based on information as of the date of this press release. Senior management has made numerous assumptions in providing this guidance which, while believed to be reasonable, may not prove to be accurate. Numerous factors, including those noted above, may cause actual results to differ materially from the guidance provided. The company expressly disclaims any current intention or obligation to update the guidance provided or any other forward-looking statement in this press release to reflect future events or changes in facts assumed for purposes of providing this guidance or otherwise affecting the forward-looking statements contained in this press release.

Non-GAAP Adjustment ItemsTo supplement our financial results prepared in accordance with U.S. GAAP, we have presented non-GAAP measures of income (loss) from operations, net income (loss) and income (loss) per diluted share, as adjusted to exclude certain goodwill and long-lived asset impairment charges, restructuring charges, executive transition costs, purchase accounting adjustments, FDA remediation costs, arbitration charges, real property tax adjustments and deferred financing write-offs in the 2011 and 2012 periods. Projected 2013 adjusted EPS will exclude the expense associated with expected 2013 restructuring and asset impairment charges related to our previously announced exits from our Hungary and Bothell, WA sites.  Exclusion of the restructuring and asset impairment expenses allows comparisons of operating results that are consistent over time.  We believe presentation of these non-GAAP measures enhances an overall understanding of our historical financial performance because we believe they are an indication of the performance of our base business. Management uses these non-GAAP measures as a
'/>"/>

SOURCE AMRI
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Quantum Materials Corporation Announces Non-Heavy Metal (Cadmium-Free) Tetrapod Quantum Dots
2. The In View Series Announces Plans for a New Series on 3D-Printing
3. Elsevier Announces the Launch of a New Journal: Journal of Forensic Radiology and Imaging
4. The In View series hosted by Larry King Announces plans for a series on Autoimmune Diseases
5. Murray Test Prep Announces the Launch of their Online Tutoring Services
6. EastBridge Investment Group Announces Completion of its Merger with Cellular Biomedicine Group - Shareholder Conference Call to be held February 8th
7. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
8. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
9. DNA Genotek Inc. Announces $10,000 GenoFIND™ Genomic Services Award
10. Spectrum Announces bioWorld Distribution Agreement
11. Life Technologies Announces Fourth Quarter and Fiscal 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Md. , June 19, 2013 Synthetic Biologics, ... the prevention and treatment of serious infectious diseases, announced today ... 6 th Annual OneMedForum New York Conference on Thursday, ... New York City . Mr. Riley is scheduled to ... webcast of Synthetic Biologics, presentation can be accessed by logging ...
(Date:6/19/2013)... Calif. , June 19, 2013 ... plant, stool and other challenging microbial nucleic acid ... Protein Extraction Kit, for extraction of pure protein ... protein world coincides with the 20 th ... growing innovation capabilities. (Photo: http://photos.prnewswire.com/prnh/20130619/LA32633 ...
(Date:6/19/2013)... 2013  Continuing its long history of proven clinical ... Coulter , Inc. announces the U.S. Food and Drug ... troponin I assay for use on its Access 2 ... Beckman Coulter,s troponin I test for over ... proven performance to continue providing dependability to laboratories supporting ...
(Date:6/19/2013)... NineSigma , Inc., of Cleveland , ... NineSights.com is now the innovation engine for the ... of innovators. From technology developers, to chemical ... out for its large community of innovators in an ... vetted by NineSigma. The community is free to join ...
Breaking Biology Technology:Synthetic Biologics to Present at OneMedForum New York 2013 2MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3
... SOUTH PLAINFIELD, N.J., Aug. 10 PTC Therapeutics, Inc. ... its collaboration with Schering-Plough Corporation (NYSE: SGP ) receiving a ... for the treatment of hepatitis C virus (HCV) infection. , ... rnh/20010919/PTCLOGO ) , , The collaboration ...
... SHANGHAI, Aug. 10 /PRNewswire-Asia-FirstCall/ -- ... "the Company"), a leading Chinese firm,specializing in ... probiotics products, today announced that the Company,s,wholly-owned ... been,awarded the High-Technology Enterprise Certificate (the "Certificate") ...
... and VANCOUVER, Aug. 10 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, ... that the United States Patent and Trademark Office ... entitled "Chemo-and Radiation-sensitization of Cancer by Antisense TRPM-2 ... cancer drug candidate, OGX-011, to treat certain cancers. ...
Cached Biology Technology:PTC Therapeutics Announces Achievement of Major Milestone in Schering-Plough Hepatitis C Collaboration 2PTC Therapeutics Announces Achievement of Major Milestone in Schering-Plough Hepatitis C Collaboration 3China-Biotics, Inc. Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate 2China-Biotics, Inc. Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate 3OncoGenex Pharmaceuticals Announces Issuance of Key Patent for OGX-011 2OncoGenex Pharmaceuticals Announces Issuance of Key Patent for OGX-011 3
(Date:6/18/2013)... DNA and this modification can occur in millions ... scientists believed that this epigenetic phenomenon actively reduced ... of researchers from the University of Geneva (UNIGE), ... the Faculty of Medicine, reveals that this is ... may play both a passive and active role ...
(Date:6/17/2013)... with severe brain infections in Vietnam. Further research is ... the symptoms of disease. , The virus was found ... with severe brain infections in the study, corresponding to ... patients with non-infectious brain disorders that were tested. , ... often fatal and patients who do survive, often young ...
(Date:6/17/2013)... of improving original foundations with more modern elements. Using ... Pittsburgh,s Kenneth P. Dietrich School of Arts and Sciences ... drug delivery, gas storage, and gas transport more efficient ... in the latest issue of the Journal of ... The recent work builds upon Pitt Associate Professor of ...
Breaking Biology News(10 mins):The secret of DNA methylation 2New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3'Chemical architects' build materials with potential applications in drug delivery and gas storage 2
... by the International Osteoporosis Foundation (IOF) show alarming projections ... the Russian Federation and many other countries in the ... conference in St. Petersburg at the IOF Summit of ... Osteoporosis, a disease of the bone which leaves people ...
... Santa Cruz, CA, USA and Oxford, UK, 27 September ... shows a new method of enzyme-controlled movement of ... The paper, by researchers at the University of ... nanopore sequencing of DNA strands. The publication describes the ...
... Carolina State University researcher has shown that water-gel-based solar ... cells to produce electricity. The findings prove the concept ... They also have the potential to be less expensive ... solar cells. The bendable devices are composed of ...
Cached Biology News:High death and disability rates due to fractures in Russia, Central Asia and Eastern Europe 2Nature Nanotechnology paper shows enzyme-controlled movement of DNA polymer through a nanopore 2Mimicking nature, water-based 'artificial leaf' produces electricity 2
... and temperature-controlled microwave oven for ... Antigen Retrieval of formalin-fixed, paraffin-embedded ... of use, high throughput (96 ... performance. When used in conjunction ...
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
...
Biology Products: